Carsten Rudolph

Carsten Rudolph is Co-founder and CEO of Ethris, a biotechnology company developing mRNA-based therapeutics and vaccines. As the lead inventor of its proprietary SNIM® RNA technology, he specialises in delivering mRNA directly to the lungs to advance treatments for respiratory diseases. He holds 15 patents and patent applications and has authored over 120 scientific publications. He is also affiliated with Dr. von Haunersche Children’s Hospital at Ludwig Maximilian University of Munich and holds a degree in pharmacy from Freie Universität Berlin.